Citius Pharmaceuticals, Inc. (CTXR)
0.5316
-0.01
(-1.59%)
USD |
NASDAQ |
Oct 02, 16:00
0.5315
0.00 (0.00%)
After-Hours: 20:00
Citius Pharmaceuticals Price to Book Value : 0.2191 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.2191 |
| October 01, 2026 | 0.2226 |
| September 30, 2026 | 0.2188 |
| September 29, 2026 | 0.2285 |
| September 28, 2026 | 0.2263 |
| September 25, 2026 | 0.2385 |
| September 24, 2026 | 0.235 |
| September 23, 2026 | 0.2343 |
| September 22, 2026 | 0.2465 |
| September 21, 2026 | 0.2376 |
| September 18, 2026 | 0.2473 |
| September 17, 2026 | 0.2423 |
| September 16, 2026 | 0.2308 |
| September 15, 2026 | 0.2308 |
| September 14, 2026 | 0.2362 |
| September 11, 2026 | 0.2394 |
| September 10, 2026 | 0.2412 |
| September 09, 2026 | 0.2399 |
| September 08, 2026 | 0.2475 |
| September 04, 2026 | 0.2422 |
| September 03, 2026 | 0.2481 |
| September 02, 2026 | 0.2388 |
| September 01, 2026 | 0.2345 |
| August 31, 2026 | 0.2391 |
| August 28, 2026 | 0.2481 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.2592 |
| August 26, 2026 | 0.2378 |
| August 25, 2026 | 0.2488 |
| August 24, 2026 | 0.2371 |
| August 21, 2026 | 0.2474 |
| August 20, 2026 | 0.2472 |
| August 19, 2026 | 0.2627 |
| August 18, 2026 | 0.2357 |
| August 17, 2026 | 0.2316 |
| August 14, 2026 | 0.3114 |
| August 13, 2026 | 0.3023 |
| August 12, 2026 | 0.3153 |
| August 11, 2026 | 0.2967 |
| August 10, 2026 | 0.279 |
| August 07, 2026 | 0.2812 |
| August 06, 2026 | 0.2646 |
| August 05, 2026 | 0.3218 |
| August 04, 2026 | 0.2565 |
| August 03, 2026 | 0.2456 |
| July 31, 2026 | 0.2349 |
| July 30, 2026 | 0.2605 |
| July 29, 2026 | 0.2345 |
| July 28, 2026 | 0.2052 |
| July 27, 2026 | 0.213 |
| July 24, 2026 | 0.2144 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.776 |
| Corcept Therapeutics, Inc. | 17.77 |
| Veru, Inc. | 1.508 |
| Johnson & Johnson | 7.256 |
| Eli Lilly & Co. | 31.76 |
Price to Book Value Related Metrics
| PS Ratio | 1.648 |
| Price | 0.5316 |
| Earnings Yield | -397.0% |
| Market Cap | 14.59M |